Post-COVID-19 SyndromeNCT05705154
Connecting Breath and Mind for CYP With Long COVID
A study testing Psychology interventions in people with Post-COVID-19 Syndrome and Anxiety, run by Royal Brompton & Harefield NHS Foundation Trust at 1 site in United Kingdom.
Trial summary
Recruitment target: Phase I: Co-design of intervention: 5 to 15 CYP aged between 12-18 years of age referred to the pan-London long COVID MDT. Phase II: Randomised pilot: 40 patients (12-18 years) will be recruited from a potential pool of 214 patients referred to the pan-London long COVID MDT. Read more about this study
- Who is it for?
- Ages 12 to 18 years
- Conditions the study is for
- Post-COVID-19 Syndrome, Anxiety, Breathlessness
- What is being tested?
- Psychology interventions
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 40 participants
- Where
- 1 siteUnited Kingdom
- Study dates
- 30 Apr 2023to 30 Mar 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 12 to 18 years
- All sexes
- No healthy volunteers
- Child, Adult
Who may be able to join
- All patients aged 12-18 years referred to the pan-London long COVID MDT with English of a standard adequate to participate in a group intervention.
Who cannot join
- No objective evidence of SARS-CoV-2 infection e.g., positive PCR testing or antibodies. Significant neurodevelopmental difficulties (severe autism spectrum disorder (ASD), attention deficit hyperactivity disorder (ADHD), global intellectual disability) and/or high psychiatric risk e.g., suicidality, severe emotional or behavioural dysregulation precluding participation in group intervention (PI screened during the MDT discussion and by lead researcher during telephone call for recruitment).
Trial locations and contacts
1 site in 1 country.
United Kingdom1 site, 1 recruiting
- Recruiting
The Royal Brompton Hospital part of Guys and St Thomas' NHS Foundation Trust
London, Chelsea, SW3 6NP
Sam Sonnappa, MD PhD, s.sonnappa@rbht.nhs.uk
Ira Jakupovic, 02073518109, i.jakupovic@rbht.nhs.uk
About this study
Official title: Connecting Breath and Mind: Development of an Online Holistic Treatment Programme Connecting Psychological Wellbeing and Breathing Techniques in Children and Young People With Long COVID
Recruitment target: Phase I: Co-design of intervention: 5 to 15 CYP aged between 12-18 years of age referred to the pan-London long COVID MDT.
Phase II: Randomised pilot: 40 patients (12-18 years) will be recruited from a potential pool of 214 patients referred to the pan-London long COVID MDT.
Read more
Methods: Phase I: Co-design Design and setting The intervention will be co-designed with CYP following a process informed by practice-base evidence, which centres the voices and wisdom of CYP, focuses on creativity and playfulness, and systemic and narrative approaches. The process will involve: 1) Refining the intentions of key stakeholders (including ways of bringing psychological and physiological principles into the intervention); 2) Participation of CYP; 3) Creativity and playfulness and 4) Responding to feedback (see Salvo et al., 2022).
Phase II. Pilot Population: 40 patients (12-18 years) will be recruited from a potential pool of 214 patients referred to the pan-London long COVID MDT. CYP will be randomised to receive either standard treatment or standard treatment plus intervention.
Study Treatment Standard treatment consists of virtual MDT discussion with referrer and advice signposting into local services for specific issues. They are sent leaflets and information. If a patient is severely affected enough to be seen face to face, they are offered an interdisciplinary consultation, and tailored input from therapies and psychological services.
Access to bite size videos and leaflets covering the following topics: sleep, pacing, activity management, school reintegration, managing friendships, eating well and emotional wellbeing. Young people are invited to a single virtual group Q\&A session to bring any queries after watching the videos.
The leaflets and online sessions have been developed by professionals from the Evelina, Great Ormond Street Hospital, Imperial, University College London Hospital, and the Whittington. The bite size videos and live sessions are delivered by a clinical psychologist, a dietitian, specialist nurse, occupational therapist, and physiotherapist. More complex or severely affected patients will receive one to one treatment with members of the MDT as required.
Intervention
Based on clinical expertise and theory, it is anticipated the following elements may be included in the intervention.:
- Progressive breathing pattern retraining, including education, self-observation, relaxation, body scanning, postural re-alignment
- Identifying the connections between body and mind to address anxiety and breathlessness
- Coping skills for managing anxiety using principles from narrative therapy and mindfulness
- Online materials to improve self-efficacy with home practice
- Social connection with other CYP for peer support, and resource sharing
- Activities to help CYP reconnect with their usual activities, skills, abilities, interests, support systems
Read the detailed description
Hypotheses: CYP with a diagnosis of Long COVID who complete the intervention in addition to standard treatment will show a greater improvement in psychological wellbeing and demonstrate fewer functional limitations of excessive breathlessness after completing a holistic modular psychological and respiratory physiotherapy (PT) intervention compared to current standard treatment alone.
Primary objective Impact score of Strength and Difficulties (SDQ) questionnaire (included in ISARIC form - standard care assessment).
-RCADS questionnaire (17), pre- and post-intervention.
Secondary Objectives
To further answer the Ho the following measures will be taken:
- Improved dysfunctional breathing measured by multi-dimensional physiotherapy assessment of breathing pattern including Nijmegen questionnaire, breathing pattern category, SMART goal setting, lung function and cardiopulmonary exercise testing and specialist physiotherapist assessment of breathing pattern quality pre- and post-intervention.
- At baseline and 6-monthly, all CYP will complete the standard assessment questionnaires for the long COVID pan-London pathway in line with the NHSE commissioning guidance which includes the following questionnaires to assess quality of life, psychological well-being, and adaptive functioning.
- Revised Children's Anxiety and Depression Scale (RCADS) questionnaire (17), pre- and post-intervention.
- EQ-5D-Y (25)
- SF-36 Quality of life (26)
- 11-item Chalder Fatigue Questionnaire (27) and
- Visual analogue pain scale
- FitBit Activity monitoring including daily step counts, daily distance travelled, daily stairs climbed, sedentary minutes, low, moderate and vigorous activity minutes, sleep hours, and wear time.
Secondary research question: Are co-designed virtual psychology and physiotherapy interventions acceptable and feasible to service users?
Quantitative data: participation, attendance and dropout rates will be collected. Technical issues with being able to access the intervention will be documented.
Qualitative feedback will be obtained to enable development of the intervention.
-The facilitators will gather live feedback towards the end of each group session using a range of approaches. As part of the focus groups the CYP will review the outcome measure to get feedback if these are the things that matter to them the most. Activities to explore outcomes that matter to CYP will be reviewed in the focus groups.
Qualitative feedback will also be obtained after completion of all the group sessions when the investigator administers the post-intervention measures. This will include measures of usefulness, willingness to recommend to a friend, and qualitative questions on experience of the group, best parts of the group, and suggestions for improvement.
The investigator will also assess the impact of prior mental health problems, severity of COVID infection (community acquired vs. hospitalised) and prior functioning on intervention response.
Study Design The project is a Pan-London research project recruiting patients from across London.
The objectives of this two-part research project are firstly to co-design a novel holistic group intervention with children and young people with long COVID. The intervention will be developed based on existing literature and interventions for psychological distress and for dysfunctional breathing in similar clinical cohorts, and from focus groups with CYP with long COVID and their parents/ caregivers to ensure acceptability and appropriateness.
The second phase of this project will be to prospectively pilot the new services to assess the efficacy, acceptability, and feasibility from both the service user and service providers. The intervention will be piloted in a cohort of CYP with long COVID as an adjunctive intervention to treatment as usual, assessing impact on well being and breathing outcomes.
Phase I. Co-design Method Design and setting The intervention will be co-designed with CYP following a process informed by practice-base evidence, which centres the voices and wisdom of CYP, focuses on creativity and playfulness, and systemic and narrative approaches. The process will involve: 1) Refining the intentions of key stakeholders (including ways of bringing psychological and physiological principles into the intervention); 2) Participation of CYP; 3) Creativity and playfulness and 4) Responding to feedback (see Salvo et al., 2022).
Participation of CYP will include:
- The use of group interventions co-designed with CYP with other conditions such as diabetes, chronic pain, myalgic encephalomyelitis/chronic fatigue syndrome and medically unexplained conditions as examples to help CYP with long COVID consider some possibilities and enable them to develop their own ideas for the intervention.
- Responding to feedback and recruitment of CYP 'advisors' (name and responsibilities included in the role to be agreed with CYP)
- The use of focus groups guided by 4Pi framework and principles (NSUN, 2015) including openness and transparency about the process, finding ways to ensure the meaningful involvement of all CYP with long COVID, including those from black and minority ethnic communities, LGBTQ+ young people and other 'marginalised' groups to co-design and develop the intervention, consider recruitment and outcome measures.
The University College London Hospitals (UCLH) psychology team have developed a number of innovative and award-winning groups (20-24) that will be used as exemplars to help young people think what they might want to be included in the groups as well as delivery style (e.g., vlogs and podcasts versus leaflet), preferred frequency and length. Parents will also be invited to attend a focus group and invited to comment on similar questions. The investigators are planning to offer the groups for the CYP unaccompanied by parents.
- As part of the focus groups the CYP will review the outcome measures to get feedback if these are the things that matter to them the most. Activities to explore outcomes that matter to CYP will be reviewed in the focus groups.
Each focus group session will be via zoom and be recorded. The recording will be downloaded to a secure encrypted hospital drive. The audio recording will be used to transcribe into a script. Once this script is checked the video and audio recordings can be deleted.
Co-design participants Service Users: The investigators aim to recruit 5 to 15 young people Inclusion: CYP aged between 12-18 years old who have been referred into the Pan-London Long COVID Multi-disciplinary Team (MDT) Clinic from its inception in 2020.
Exclusion: No objective evidence of SARS-CoV-2 infection e.g., positive PCR testing or antibodies. Significant neurodevelopmental difficulties (severe autism spectrum disorder (ASD), attention deficit hyperactivity disorder (ADHD), global intellectual disability) and/or high psychiatric risk e.g., suicidality, severe emotional or behavioural dysregulation precluding participation in group intervention (PI screened during the MDT discussion and by lead researcher during telephone call for recruitment).
Phase II. Pilot Population: 40 patients (12-18 years) will be recruited from a potential pool of 214 patients referred to the pan-London long COVID MDT.
Inclusion criteria: All patients aged 12-18 years referred to the pan-London long COVID MDT with English of a standard adequate to participate in a group intervention.
Exclusion criteria: No objective evidence of SARS-CoV-2 infection e.g., positive PCR testing or antibodies. Significant neurodevelopmental difficulties (severe autism spectrum disorder (ASD), attention deficit hyperactivity disorder (ADHD), global intellectual disability) and/or high psychiatric risk e.g., suicidality, severe emotional or behavioral dysregulation precluding participation in group intervention (PI screened during the MDT discussion and by lead researcher during telephone call for recruitment).
Process: Informed consent or assent will be obtained from all CYP, and parental consent obtained for CYP under 16 years. Parents will be given access to all resources, although the intervention will be targeted towards the CYP.
Each CYP will complete a screening assessment for suitability for the trial. Once a potential participant has consented to take part they will have a Cardio-Pulmonary Exercise Test (CPET) test, lung function, 1:1 breathing pattern assessment by a respiratory physiotherapist and set up with a FitBit monitor before randomisation.
Each Fitbit will be set up by the lead researcher to a new outlook account linked to the participant number. The research team will be able to download data on daily step counts, daily distance travelled, daily stairs climbed, sedentary minutes, low, moderate and vigorous activity minutes, sleep hours, and wear time. The Fitbit will be synced to the patient's mobile phone in clinic so they can review their daily data as well. The Fitbit account will be set up with a generic date of birth, weight, and height so not to identify the patient.
CYP will be randomised (using a block randomisation approach) to receive either standard treatment or standard treatment plus intervention.
Standard treatment consists of virtual MDT discussion with referrer and advice signposting into local services for specific issues. They are sent leaflets and info on online videos (webinars) and directed to standardised information on the Your COVID Recovery Website If a patient is severely affected enough to be seen face to face, they are offered an interdisciplinary consultation, and tailored input from PT, occupational therapy (OT) and psychological services.
Access to bite size videos and leaflets and other standardised information covering the following topics: sleep, pacing, activity management, school reintegration, managing friendships, eating well and emotional wellbeing. Young people are invited to a single virtual group Q\&A session to bring any queries after watching the videos/ webinars.
The leaflets have and online sessions have been developed by professionals from the Evelina, Great Ormond Street Hospital, Imperial, University College London Hospital, and the Whittington. Additional information is being developed in online video/ webinar form as the services evolve. The bite size videos/ webinars and live sessions are delivered by a clinical psychologist, a dietician, specialist nurse, occupational therapist and physiotherapist. More complex or severely affected patients will receive one to one treatment with members of the MDT as required.
Intervention
Based on clinical expertise and theory, it is anticipated the following elements may be included in the intervention:
- Progressive breathing pattern retraining, including education, self-observation, relaxation, body scanning, postural re-alignment
- Identifying the connections between body and mind to address anxiety and breathlessness
- Coping skills for managing anxiety using principles from narrative therapy and mindfulness
- Online materials to improve self-efficacy with home practice
- Social connection with other CYP for peer support, and resource sharing
- Activities to help CYP reconnect with their usual activities, skills, abilities, interests, support systems.
- Conditions
- Post-COVID-19 Syndrome, Anxiety, Breathlessness
- Being tested
- Psychology interventions
- Keywords
- Teenager, Adolescent
- Medical subject headings
- Post-Acute COVID-19 Syndrome, Anxiety Disorders, Dyspnea
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Psychology interventionsBehavioural
Also called breathing pattern retraining
Based on clinical expertise and theory, it is anticipated the following elements may be included in the intervention:
- Progressive breathing pattern retraining, including education, self-observation, relaxation, body scanning, postural re-alignment
- Identifying the connections between body and mind to address anxiety and breathlessness
- Coping skills for managing anxiety using principles from narrative therapy and mindfulness
- Online materials to improve self-efficacy with home practice
- Social connection with other CYP for peer support, and resource sharing
- Activities to help CYP reconnect with their usual activities, skills, abilities, interests, support systems.
| Study group | Role | What they receive |
|---|---|---|
| Standard treatment | Active comparator | Standard treatment consists of virtual MDT discussion with referrer and advice signposting into local services for specific issues. If a patient is severely affected enough to be seen face to face, they are offered an interdisciplinary consultation, and tailored input from PT OT and psychological services.
Access to standardised information covering the following topics: sleep, pacing, activity management, school reintegration, managing friendships, eating well and emotional wellbeing.
More complex or severely affected patients will receive one to one treatment with members of the MDT as required. Receives: Behavioral: Psychology interventions |
| Intervention | Experimental | As above standard intervention plus the new co-designed intervention.
Based on clinical expertise and theory, it is anticipated the following elements may be included in the intervention:
* Progressive breathing pattern retraining, including education, self-observation, relaxation, body scanning, postural re-alignment
* Identifying the connections between body and mind to address anxiety and breathlessness
* Coping skills for managing anxiety using principles from narrative therapy and mindfulness
* Online materials to improve self-efficacy with home practice
* Social connection with other CYP for peer support, and resource sharing
* Activities to help CYP reconnect with their usual activities, skills, abilities, interests, support systems. Receives: Behavioral: Psychology interventions |
What is being measured
The primary outcome is the main question the study is designed to answer.
Impact score of Strength and Difficulties (SDQ) questionnaire
25 item questionnaire comprising of 5 scales of 5 items
Measured: Through study completion, an average of 24 weeks
Secondary outcomes (8)
Revised Childhood Anxiety and Depression Scale (RCADS) questionnaire
The revised Child Anxiety and Depression Scale is a 47 item youth self reported questionnaire with subscales
Measured: Through study completion, an average of 24 weeks
EQ-5D-Y
The EQ-5D-Y descriptive system comprises of the five dimensions: mobility, looking after myself, doing usual activities, having pain or discomfort and feeling worried/ sad/ unhappy
Measured: Through study completion, an average of 24 weeks
SF-36 Quality of Life
36 item health survey - self reported quality of life measure
Measured: Through study completion, an average of 24 weeks
11 item Chandler Fatigue Questionnaire
11 item questionnaire is divided into two components, one that measures physical fatigue and on that measures mental fatigue
Measured: Through study completion, an average of 24 weeks
Visual Analogue Scale (VAS) Pain scale
0-10 visual analogue scale of self reported pain
Measured: Through study completion, an average of 24 weeks
FitBit Activity monitoring
Daily step count, daily distance travelled, daily stairs climbed, sedentary minutes, low, moderate and vigorous activity minutes, sleep hours and wear time
Measured: Through study completion, an average of 24 weeks
Physiotherapy assessment of dysfunctional breathing
Multi-dimensional physiotherapy assessment of breathing pattern
Measured: Through study completion, an average of 24 weeks
Qualitative feedback
concurrent and retrospective feedback on the standard and new intervention
Measured: Through study completion, an average of 24 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted30 Jan 2023
- Study start30 Apr 2023
- Primary completion30 Mar 2024 (estimated)
- Study completion30 Mar 2024 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Post-COVID-19 SyndromeStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Participants will be randomised using block randomisation into either standard intervention arm or standard intervention plus the new co-designed intervention.
- Masking
- None (open label)
- Enrolment
- 40 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Royal Brompton & Harefield NHS Foundation Trust
- Sponsor type
- University, hospital or other
- Collaborators
- Guy's and St Thomas' NHS Foundation Trust, University College London Hospitals
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05705154
- Sponsor's protocol ID
- 315063
- Status last verified
- Sep 2023
- First submitted
- 15 Dec 2022
- Last updated
- 8 Sep 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: All data will be handled in accordance with the Data Protection Act (2018), National Health Service (NHS) Caldecott Principles, The United Kingdom Policy Framework for Health and Social Care Research, and the condition of the Research Ethics Committee (REC) approval. The Case Report Forms (CRFs) will not bear the subject's name or other personal identifiable data. The subject's study Identification Number (ID) will be used for identification. No data will be shared with any external organisation without appropriate consent and data sharing agreement in place, as applicable.
Study at a glance
From the registry record, last updated by the sponsor on 8 Sep 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Connecting Breath and Mind: Development of an Online Holistic Treatment Programme Connecting Psychological Wellbeing and Breathing Techniques in Children and Young People With Long COVID
- ClinicalTrials.gov ID
- NCT05705154
- Acronym / sponsor ID
- 315063
- Conditions
- Post-COVID-19 Syndrome, Anxiety, Breathlessness
- Keywords
- Teenager, Adolescent
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 40 participants (estimated)
- Lead sponsor
- Royal Brompton & Harefield NHS Foundation TrustUniversity, hospital or other
- Collaborators
- Guy's and St Thomas' NHS Foundation Trust, University College London Hospitals
- Study start
- 30 Apr 2023 (actual)
- Primary completion
- 30 Mar 2024 (estimated)
- Study completion
- 30 Mar 2024 (estimated)
- First posted
- 30 Jan 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Recruitment target: Phase I: Co-design of intervention: 5 to 15 CYP aged between 12-18 years of age referred to the pan-London long COVID MDT.
Phase II: Randomised pilot: 40 patients (12-18 years) will be recruited from a potential pool of 214 patients referred to the pan-London long COVID MDT.
Methods: Phase I: Co-design Design and setting The intervention will be co-designed with CYP following a process informed by practice-base evidence, which centres the voices and wisdom of CYP, focuses on creativity and playfulness, and systemic and narrative approaches. The process will involve: 1) Refining the intentions of key stakeholders (including ways of bringing psychological and physiological principles into the intervention); 2) Participation of CYP; 3) Creativity and playfulness and 4) Responding to feedback (see Salvo et al., 2022).
Phase II. Pilot Population: 40 patients (12-18 years) will be recruited from a potential pool of 214 patients referred to the pan-London long COVID MDT. CYP will be randomised to receive either standard treatment or standard treatment plus intervention.
Study Treatment Standard treatment consists of virtual MDT discussion with referrer and advice signposting into local services for specific issues. They are sent leaflets and information. If a patient is severely affected enough to be seen face to face, they are offered an interdisciplinary consultation, and tailored input from therapies and psychological services.
Access to bite size videos and leaflets covering the following topics: sleep, pacing, activity management, school reintegration, managing friendships, eating well and emotional wellbeing. Young people are invited to a single virtual group Q\&A session to bring any queries after watching the videos.
The leaflets and online sessions have been developed by professionals from the Evelina, Great Ormond Street Hospital, Imperial, University College London Hospital, and the Whittington. The bite size videos and live sessions are delivered by a clinical psychologist, a dietitian, specialist nurse, occupational therapist, and physiotherapist. More complex or severely affected patients will receive one to one treatment with members of the MDT as required.
Intervention
Based on clinical expertise and theory, it is anticipated the following elements may be included in the intervention.:
- Progressive breathing pattern retraining, including education, self-observation, relaxation, body scanning, postural re-alignment
- Identifying the connections between body and mind to address anxiety and breathlessness
- Coping skills for managing anxiety using principles from narrative therapy and mindfulness
- Online materials to improve self-efficacy with home practice
- Social connection with other CYP for peer support, and resource sharing
- Activities to help CYP reconnect with their usual activities, skills, abilities, interests, support systems
Detailed description
Hypotheses: CYP with a diagnosis of Long COVID who complete the intervention in addition to standard treatment will show a greater improvement in psychological wellbeing and demonstrate fewer functional limitations of excessive breathlessness after completing a holistic modular psychological and respiratory physiotherapy (PT) intervention compared to current standard treatment alone.
Primary objective Impact score of Strength and Difficulties (SDQ) questionnaire (included in ISARIC form - standard care assessment).
-RCADS questionnaire (17), pre- and post-intervention.
Secondary Objectives
To further answer the Ho the following measures will be taken:
- Improved dysfunctional breathing measured by multi-dimensional physiotherapy assessment of breathing pattern including Nijmegen questionnaire, breathing pattern category, SMART goal setting, lung function and cardiopulmonary exercise testing and specialist physiotherapist assessment of breathing pattern quality pre- and post-intervention.
- At baseline and 6-monthly, all CYP will complete the standard assessment questionnaires for the long COVID pan-London pathway in line with the NHSE commissioning guidance which includes the following questionnaires to assess quality of life, psychological well-being, and adaptive functioning.
- Revised Children's Anxiety and Depression Scale (RCADS) questionnaire (17), pre- and post-intervention.
- EQ-5D-Y (25)
- SF-36 Quality of life (26)
- 11-item Chalder Fatigue Questionnaire (27) and
- Visual analogue pain scale
- FitBit Activity monitoring including daily step counts, daily distance travelled, daily stairs climbed, sedentary minutes, low, moderate and vigorous activity minutes, sleep hours, and wear time.
Secondary research question: Are co-designed virtual psychology and physiotherapy interventions acceptable and feasible to service users?
Quantitative data: participation, attendance and dropout rates will be collected. Technical issues with being able to access the intervention will be documented.
Qualitative feedback will be obtained to enable development of the intervention.
-The facilitators will gather live feedback towards the end of each group session using a range of approaches. As part of the focus groups the CYP will review the outcome measure to get feedback if these are the things that matter to them the most. Activities to explore outcomes that matter to CYP will be reviewed in the focus groups.
Qualitative feedback will also be obtained after completion of all the group sessions when the investigator administers the post-intervention measures. This will include measures of usefulness, willingness to recommend to a friend, and qualitative questions on experience of the group, best parts of the group, and suggestions for improvement.
The investigator will also assess the impact of prior mental health problems, severity of COVID infection (community acquired vs. hospitalised) and prior functioning on intervention response.
Study Design The project is a Pan-London research project recruiting patients from across London.
The objectives of this two-part research project are firstly to co-design a novel holistic group intervention with children and young people with long COVID. The intervention will be developed based on existing literature and interventions for psychological distress and for dysfunctional breathing in similar clinical cohorts, and from focus groups with CYP with long COVID and their parents/ caregivers to ensure acceptability and appropriateness.
The second phase of this project will be to prospectively pilot the new services to assess the efficacy, acceptability, and feasibility from both the service user and service providers. The intervention will be piloted in a cohort of CYP with long COVID as an adjunctive intervention to treatment as usual, assessing impact on well being and breathing outcomes.
Phase I. Co-design Method Design and setting The intervention will be co-designed with CYP following a process informed by practice-base evidence, which centres the voices and wisdom of CYP, focuses on creativity and playfulness, and systemic and narrative approaches. The process will involve: 1) Refining the intentions of key stakeholders (including ways of bringing psychological and physiological principles into the intervention); 2) Participation of CYP; 3) Creativity and playfulness and 4) Responding to feedback (see Salvo et al., 2022).
Participation of CYP will include:
- The use of group interventions co-designed with CYP with other conditions such as diabetes, chronic pain, myalgic encephalomyelitis/chronic fatigue syndrome and medically unexplained conditions as examples to help CYP with long COVID consider some possibilities and enable them to develop their own ideas for the intervention.
- Responding to feedback and recruitment of CYP 'advisors' (name and responsibilities included in the role to be agreed with CYP)
- The use of focus groups guided by 4Pi framework and principles (NSUN, 2015) including openness and transparency about the process, finding ways to ensure the meaningful involvement of all CYP with long COVID, including those from black and minority ethnic communities, LGBTQ+ young people and other 'marginalised' groups to co-design and develop the intervention, consider recruitment and outcome measures.
The University College London Hospitals (UCLH) psychology team have developed a number of innovative and award-winning groups (20-24) that will be used as exemplars to help young people think what they might want to be included in the groups as well as delivery style (e.g., vlogs and podcasts versus leaflet), preferred frequency and length. Parents will also be invited to attend a focus group and invited to comment on similar questions. The investigators are planning to offer the groups for the CYP unaccompanied by parents.
- As part of the focus groups the CYP will review the outcome measures to get feedback if these are the things that matter to them the most. Activities to explore outcomes that matter to CYP will be reviewed in the focus groups.
Each focus group session will be via zoom and be recorded. The recording will be downloaded to a secure encrypted hospital drive. The audio recording will be used to transcribe into a script. Once this script is checked the video and audio recordings can be deleted.
Co-design participants Service Users: The investigators aim to recruit 5 to 15 young people Inclusion: CYP aged between 12-18 years old who have been referred into the Pan-London Long COVID Multi-disciplinary Team (MDT) Clinic from its inception in 2020.
Exclusion: No objective evidence of SARS-CoV-2 infection e.g., positive PCR testing or antibodies. Significant neurodevelopmental difficulties (severe autism spectrum disorder (ASD), attention deficit hyperactivity disorder (ADHD), global intellectual disability) and/or high psychiatric risk e.g., suicidality, severe emotional or behavioural dysregulation precluding participation in group intervention (PI screened during the MDT discussion and by lead researcher during telephone call for recruitment).
Phase II. Pilot Population: 40 patients (12-18 years) will be recruited from a potential pool of 214 patients referred to the pan-London long COVID MDT.
Inclusion criteria: All patients aged 12-18 years referred to the pan-London long COVID MDT with English of a standard adequate to participate in a group intervention.
Exclusion criteria: No objective evidence of SARS-CoV-2 infection e.g., positive PCR testing or antibodies. Significant neurodevelopmental difficulties (severe autism spectrum disorder (ASD), attention deficit hyperactivity disorder (ADHD), global intellectual disability) and/or high psychiatric risk e.g., suicidality, severe emotional or behavioral dysregulation precluding participation in group intervention (PI screened during the MDT discussion and by lead researcher during telephone call for recruitment).
Process: Informed consent or assent will be obtained from all CYP, and parental consent obtained for CYP under 16 years. Parents will be given access to all resources, although the intervention will be targeted towards the CYP.
Each CYP will complete a screening assessment for suitability for the trial. Once a potential participant has consented to take part they will have a Cardio-Pulmonary Exercise Test (CPET) test, lung function, 1:1 breathing pattern assessment by a respiratory physiotherapist and set up with a FitBit monitor before randomisation.
Each Fitbit will be set up by the lead researcher to a new outlook account linked to the participant number. The research team will be able to download data on daily step counts, daily distance travelled, daily stairs climbed, sedentary minutes, low, moderate and vigorous activity minutes, sleep hours, and wear time. The Fitbit will be synced to the patient's mobile phone in clinic so they can review their daily data as well. The Fitbit account will be set up with a generic date of birth, weight, and height so not to identify the patient.
CYP will be randomised (using a block randomisation approach) to receive either standard treatment or standard treatment plus intervention.
Standard treatment consists of virtual MDT discussion with referrer and advice signposting into local services for specific issues. They are sent leaflets and info on online videos (webinars) and directed to standardised information on the Your COVID Recovery Website If a patient is severely affected enough to be seen face to face, they are offered an interdisciplinary consultation, and tailored input from PT, occupational therapy (OT) and psychological services.
Access to bite size videos and leaflets and other standardised information covering the following topics: sleep, pacing, activity management, school reintegration, managing friendships, eating well and emotional wellbeing. Young people are invited to a single virtual group Q\&A session to bring any queries after watching the videos/ webinars.
The leaflets have and online sessions have been developed by professionals from the Evelina, Great Ormond Street Hospital, Imperial, University College London Hospital, and the Whittington. Additional information is being developed in online video/ webinar form as the services evolve. The bite size videos/ webinars and live sessions are delivered by a clinical psychologist, a dietician, specialist nurse, occupational therapist and physiotherapist. More complex or severely affected patients will receive one to one treatment with members of the MDT as required.
Intervention
Based on clinical expertise and theory, it is anticipated the following elements may be included in the intervention:
- Progressive breathing pattern retraining, including education, self-observation, relaxation, body scanning, postural re-alignment
- Identifying the connections between body and mind to address anxiety and breathlessness
- Coping skills for managing anxiety using principles from narrative therapy and mindfulness
- Online materials to improve self-efficacy with home practice
- Social connection with other CYP for peer support, and resource sharing
- Activities to help CYP reconnect with their usual activities, skills, abilities, interests, support systems.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- Participants will be randomised using block randomisation into either standard intervention arm or standard intervention plus the new co-designed intervention.
| Arm | Type | Receives |
|---|---|---|
| Standard treatment | Active comparator | Behavioral: Psychology interventionsStandard treatment consists of virtual MDT discussion with referrer and advice signposting into local services for specific issues. If a patient is severely affected enough to be seen face to face, they are offered an interdisciplinary consultation, and tailored input from PT OT and psychological services. Access to standardised information covering the following topics: sleep, pacing, activity management, school reintegration, managing friendships, eating well and emotional wellbeing. More complex or severely affected patients will receive one to one treatment with members of the MDT as required. |
| Intervention | Experimental | Behavioral: Psychology interventionsAs above standard intervention plus the new co-designed intervention. Based on clinical expertise and theory, it is anticipated the following elements may be included in the intervention: * Progressive breathing pattern retraining, including education, self-observation, relaxation, body scanning, postural re-alignment * Identifying the connections between body and mind to address anxiety and breathlessness * Coping skills for managing anxiety using principles from narrative therapy and mindfulness * Online materials to improve self-efficacy with home practice * Social connection with other CYP for peer support, and resource sharing * Activities to help CYP reconnect with their usual activities, skills, abilities, interests, support systems. |
Who may qualify
- Ages
- 12 to 18 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult
Key inclusion criteria (1 listed)
- All patients aged 12-18 years referred to the pan-London long COVID MDT with English of a standard adequate to participate in a group intervention.
Key exclusion criteria (1 listed)
- No objective evidence of SARS-CoV-2 infection e.g., positive PCR testing or antibodies. Significant neurodevelopmental difficulties (severe autism spectrum disorder (ASD), attention deficit hyperactivity disorder (ADHD), global intellectual disability) and/or high psychiatric risk e.g., suicidality, severe emotional or behavioural dysregulation precluding participation in group intervention (PI screened during the MDT discussion and by lead researcher during telephone call for recruitment).
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Psychology interventionsAlso: breathing pattern retrainingBased on clinical expertise and theory, it is anticipated the following elements may be included in the intervention: * Progressive breathing pattern retraining, including education, self-observation, relaxation, body scanning, postural re-alignment * Identifying the connections between body and mind to address anxiety and breathlessness * Coping skills for managing anxiety using principles from narrative therapy and mindfulness * Online materials to improve self-efficacy with home practice * Social connection with other CYP for peer support, and resource sharing * Activities to help CYP reconnect with their usual activities, skills, abilities, interests, support systems. | Behavioural | Intervention, Standard treatment |
Primary outcome
Impact score of Strength and Difficulties (SDQ) questionnaire
Time frame: Through study completion, an average of 24 weeks
25 item questionnaire comprising of 5 scales of 5 items
8 secondary outcomes
Revised Childhood Anxiety and Depression Scale (RCADS) questionnaire
Time frame: Through study completion, an average of 24 weeks
EQ-5D-Y
Time frame: Through study completion, an average of 24 weeks
SF-36 Quality of Life
Time frame: Through study completion, an average of 24 weeks
11 item Chandler Fatigue Questionnaire
Time frame: Through study completion, an average of 24 weeks
Visual Analogue Scale (VAS) Pain scale
Time frame: Through study completion, an average of 24 weeks
FitBit Activity monitoring
Time frame: Through study completion, an average of 24 weeks
Physiotherapy assessment of dysfunctional breathing
Time frame: Through study completion, an average of 24 weeks
Qualitative feedback
Time frame: Through study completion, an average of 24 weeks
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 Sep 2023.
- Individual participant dataSharing planned: No. All data will be handled in accordance with the Data Protection Act (2018), National Health Service (NHS) Caldecott Principles, The United Kingdom Policy Framework for Health and Social Care Research, and the condition of the Research Ethics Committee (REC) approval. The Case Report Forms (CRFs) will not bear the subject's name or other personal identifiable data. The subject's study Identification Number (ID) will be used for identification. No data will be shared with any external organisation without appropriate consent and data sharing agreement in place, as applicable.
Related trials for Post-COVID-19 Syndrome
Not yet recruitingPhase 1
Phase I Open-Label Safety Trial of Pembrolizumab for Neurological Post- Acute Sequelae of SARS-CoV-2 (PD1-PASC I)
Post-Acute COVID-19 Syndrome
Recruiting
Whole-body Cryotherapy in Those With Chronic Fatigue: A Feasibility Study
ME/CFS, Fibromyalgia (FM)
Not yet recruitingPhase 3
The Study of Brave-LC LDN Treatment Trial
Post-acute COVID-19 Syndrome
Active, not recruitingObservational study
Epigenetic Changes in Long COVID Patients
Long COVID-19 Syndrome, Long COVID Symptoms
Enrolling by invitationPhase 2
Immunotherapy for Neurological Post-Acute Sequelae of SARS-CoV-2
Systemic Inflammation, Neuroinflammation
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Psychology interventions in people with Post-COVID-19 Syndrome and Anxiety, run by Royal Brompton & Harefield NHS Foundation Trust at 1 site in United Kingdom.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 8 Sep 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Samatha Sonnappa, MD PhD (02073528121, s.sonnappa@rbht.nhs.uk), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Impact score of Strength and Difficulties (SDQ) questionnaire (time frame: Through study completion, an average of 24 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Sep 2023.